FDA工艺验证指南Word文档下载推荐.docx

上传人:b****2 文档编号:4082155 上传时间:2023-05-02 格式:DOCX 页数:23 大小:26.11KB
下载 相关 举报
FDA工艺验证指南Word文档下载推荐.docx_第1页
第1页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第2页
第2页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第3页
第3页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第4页
第4页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第5页
第5页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第6页
第6页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第7页
第7页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第8页
第8页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第9页
第9页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第10页
第10页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第11页
第11页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第12页
第12页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第13页
第13页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第14页
第14页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第15页
第15页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第16页
第16页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第17页
第17页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第18页
第18页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第19页
第19页 / 共23页
FDA工艺验证指南Word文档下载推荐.docx_第20页
第20页 / 共23页
亲,该文档总共23页,到这儿已超出免费预览范围,如果喜欢就下载吧!
下载资源
资源描述

FDA工艺验证指南Word文档下载推荐.docx

《FDA工艺验证指南Word文档下载推荐.docx》由会员分享,可在线阅读,更多相关《FDA工艺验证指南Word文档下载推荐.docx(23页珍藏版)》请在冰点文库上搜索。

FDA工艺验证指南Word文档下载推荐.docx

acceptableelementsofprocessvalidationforthepreparationof

humanandanimaldrugproductsandmedicaldevices.

II.SCOPE

ThisguidelineisissuedunderSection10.90(21CFR10.90)andis

applicabletothemanufactureofpharmaceuticalsandmedical

devices.Itstatesprinciplesandpracticesofgeneral

applicabilitythatarenotlegalrequirementsbutareacceptableto

theFDA.Apersonmayrelyuponthisguidelinewiththeassurance

ofitsacceptabilitytoFDA,ormayfollowdifferentprocedures.

Whendifferentproceduresareused,apersonmay,butisnot

requiredto,discussthematterinadvancewithFDAtopreventthe

expenditureofmoneyandeffortonactivitiesthatmaylaterbe

determinedtobeunacceptable.Inshort,thisguidelinelists

principlesandpracticeswhichareacceptabletotheFDAforthe

processvalidationofdrugproductsandmedicaldevices;

itdoes

notlisttheprinciplesandpracticesthatmust,inallinstances,

beusedtocomplywithlaw.

-1-

Thisguidelinemaybeamendedfromtimetotime.Interested

personsareinvitedtosubmitcommentsonthisdocumentandany

subsequentrevisions.Writtencommentsshouldbesubmittedtothe

DocketsManagementBranch(HFA-305),FoodandDrugAdministration,

Room4-62,5600FishersLane,Rockville,Maryland20857.Received

commentsmaybeseeninthatofficebetween9\a.m.and4\p.m.,

MondaythroughFriday.

III.INTRODUCTION

ProcessvalidationisarequirementoftheCurrentGood

ManufacturingPracticesRegulationsforFinishedPharmaceuticals,

21CFRParts210and211,andoftheGoodManufacturingPractice

RegulationsforMedicalDevices,21CFRPart820,andtherefore,is

applicabletothemanufactureofpharamaceuticalsandmedical

devices.

SeveralfirmshaveaskedFDAforspecificguidanceonwhatFDA

expectsfirmstodotoassurecompliancewiththerequirementsfor

processvalidation.Thisguidelinediscussesprocessvalidation

elementsandconceptsthatareconsideredbyFDAasacceptable

partsofavalidationprogram.Theconstituentsofvalidation

presentedinthisdocumentarenotintendedtobeall-inclusive.

FDArecognizesthat,becauseofthegreatvarietyofmedical

products(drugproductsandmedicaldevices),processesand

-2-

manufacturingfacilities,itisnotpossibletostateinone

documentallofthespecificvalidationelementsthatare

applicable.Severalbroadconcepts,however,havegeneral

applicabilitywhichmanufacturerscanusesuccessfullyasaguide

invalidatingamanufacturingprocess.Althoughtheparticular

requirementsofprocessvalidationwillvaryaccordingtosuch

factorsasthenatureofthemedicalproduct(e.g.,sterilevs

non-sterile)andthecomplexityoftheprocess,thebroadconcepts

statedinthisdocumenthavegeneralapplicabilityandprovidean

acceptableframeworkforbuildingacomprehensiveapproachto

processvalidation.

Definitions

Installationqualification-Establishingconfidencethatprocess

equipmentandancillarysystemsarecapableofconsistently

operatingwithinestablishedlimitsandtolerances.

Processperformancequalification-Establishingconfidencethat

theprocessiseffectiveandreproducible.

Productperformancequalification-Establishingconfidencethrough

appropriatetestingthatthefinishedproductproducedbya

specifiedprocessmeetsallreleaserequirementsforfunctionality

andsafety.

-3-

Prospectivevalidation-Validationconductedpriortothe

distributionofeitheranewproduct,orproductmadeundera

revisedmanufacturingprocess,wheretherevisionsmayaffectthe

product'

scharacteristics.

Retrospectivevalidation-Validationofaprocessforaproduct

alreadyindistributionbaseduponaccumulatedproduction,testing

andcontroldata.

Validation-Establishingdocumentedevidencewhichprovidesahigh

degreeofassurancethataspecificprocesswillconsistently

produceaproductmeetingitspre-determinedspecificationsand

qualityattributes.

Validationprotocol-Awrittenplanstatinghowvalidationwillbe

conducted,includingtestparameters,productcharacteristics,

productionequipment,anddecisionpointsonwhatconstitutes

acceptabletestresults.

Worstcase-Asetofconditionsencompassingupperandlower

processinglimitsandcircumstances,includingthosewithin

standardoperatingprocedures,whichposethegreatestchanceof

processorproductfailurewhencomparedtoidealconditions.Such

conditionsdonotnecessarilyinduceproductorprocessfailure.

-4-

IV.GENERALCONCEPTS

Assuranceofproductqualityisderivedfromcarefulattentiontoa

numberoffactorsincludingselectionofqualitypartsand

materials,adequateproductandprocessdesign,controlofthe

process,andin-processandend-producttesting.Duetothe

complexityoftoday'

smedicalproducts,routineend-producttesting

aloneoftenisnotsufficienttoassureproductqualityforseveral

reasons.Someend-producttestshavelimitedsensitivity.1In

somecases,destructivetestingwouldberequiredtoshowthatthe

manufacturingprocesswasadequate,andinothersituations

end-producttestingdoesnotrevealallvariationsthatmayoccur

intheproductthatmayimpactonsafetyandeffectiveness.2

Thebasicprinciplesofqualityassurancehaveastheirgoalthe

productionofarticlesthatarefitfortheirintendeduse.These

1Forexample,USPXXIstates:

"

Nosamplingplanforapplying

sterilityteststoaspecifiedproportionofdiscreteunits

selectedfromasterilizationloadiscapableofdemonstratingwith

completeassurancethatalloftheuntestedunitsareinfact

sterile."

2Asanexample,inoneinstanceavisualinspectionfailedtodetect

adefectivestructuralweldwhichresultedinthefailureofan

infantwarmer.Thedefectcouldonlyhavebeendetectedbyusing

destructivetestingorexpensivetestequipment.

-5-

principlesmaybestatedasfollows:

(1)quality,safety,and

effectivenessmustbedesignedandbuiltintotheproduct;

(2)

qualitycannotbeinspectedortestedintothefinishedproduct;

and(3)eachstepofthemanufacturingprocessmustbecontrolled

tomaximizetheprobabilitythatthefinishedproductmeetsall

qualityanddesignspecifications.Processvalidationisakey

elementinassuringthatthesequalityassurancegoalsaremet.

Itisthroughcarefuldesignandvalidationofboththeprocessand

processcontrolsthatamanufacturercanestablishahighdegreeof

confidencethatallmanufacturedunitsfromsuccessivelotswillbe

acceptable.Successfullyvalidatingaprocessmayreducethe

dependenceuponintensivein-processandfinishedproducttesting.

Itshouldbenotedthatinmostallcases,end-producttesting

playsamajorroleinassuringthatqualityassurancegoalsare

met;

i.e.,validationandend-producttestingarenotmutually

exclusive.

TheFDAdefinesprocessvalidationasfollows:

Processvalidationisestablishingdocumentedevidencewhich

providesahighdegreeofassurancethataspecificprocesswill

consistentlyproduceaproductmeetingitspre-determined

specificationsandqualitycharacteristics.

-6-

Itisimportantthatthemanufacturerprepareawrittenvalidation

protocolwhichspecifiestheprocedures(andtests)tobeconducted

andthedatatobecollected.Thepurposeforwhichdataare

collectedmustbeclear,thedatamustreflectfactsandbe

collectedcarefullyandaccurately.Theprotocolshouldspecifya

sufficientnumberofreplicateprocessrunstodemonstrate

reproducibilityandprovideanaccuratemeasureofvariability

amongsuccessiveruns.Thetestconditionsfortheserunsshould

encompassupperandlowerprocessinglimitsandcircumstances,

includingthosewithinstandardoperatingprocedures,whichpose

thegreatestchanceofprocessorproductfailurecomparedtoideal

conditions;

suchconditionshavebecomewidelyknownas"

worst

case"

conditions.(Theyaresometimescalled"

mostappropriate

challenge"

conditions.)Validationdocumentationshouldinclude

evidenceofthesuitabilityofmaterialsandtheperformanceand

reliabilityofequipmentandsystems.

Keyprocessvariablesshouldbemonitoredanddocumented.Analysis

ofthedatacollectedfrommonitoringwillestablishthe

variabilityofprocessparametersforindividualrunsandwill

establishwhetherornottheequipmentandprocesscontrolsare

adequatetoassurethatproductspecificationsaremet.

-7-

Finishedproductandin-processtestdatacanbeofvaluein

processvalidation,particularlyinthosesituationswherequality

attributesandvariabilitiescanbereadilymeasured.Where

finished(orin-process)testingcannotadequatelymeasurecertain

attributes,processvalidationshouldbederivedprimarilyfrom

qualificationofeachsystemusedinproductionandfrom

considerationoftheinteractionofthevarioussystems.

V.CGMPREGULATIONSFORFINISHEDPHARMACEUTICALS

Processvalidationisrequired,inbothgeneralandspecificterms,

bytheCurrentGoodManufacturingPracticeRegulationsforFinished

Ph

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 工作范文 > 行政公文

copyright@ 2008-2023 冰点文库 网站版权所有

经营许可证编号:鄂ICP备19020893号-2